Phio Pharmaceuticals Corp. Common Stock (PHIO) is a publicly traded Healthcare sector company. As of May 21, 2026, PHIO trades at $1.08 with a market cap of $12.55M and a P/E ratio of -0.74. PHIO moved +0.00% today. Year to date, PHIO is -7.69%; over the trailing twelve months it is -40.98%. Its 52-week range spans $0.81 to $9.79. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces PHIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Phio Pharmaceuticals Corp. Common Stock (PHIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PHIO moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.08 |
| Market Cap | $12.55M |
| P/E Ratio | -0.74 |
| EPS | $-1.45 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.79 |
| 52-Week Low | $0.81 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-8.70M |
| Gross Margin | 0.00% |
1 analysts cover PHIO: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.